UTHR
NASDAQ · Biotechnology
United Therapeutics Corp
$497.59
+4.49 (+0.91%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+14.64%
YTD
+0.18%
Open$493.98
Previous Close$493.10
Day High$499.58
Day Low$488.08
52W High$609.35
52W Low$397.97
Volume—
Avg Volume732.0K
Market Cap21.24B
P/E Ratio16.20
EPS$27.96
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$485.49
Above
SMA 200
$394.55
Above
RSI (14)
60.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-82.2% upside
Current
$497.59
$497.59
Target
$88.53
$88.53
$65.70
$88.53 avg
$121.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.85B | 2.42B | 2.73B |
| Net Income | 1.20B | 912.44M | 406.29M |
| Profit Margin | 41.9% | 39.8% | 14.9% |
| EBITDA | 1.41B | 1.14B | 733.08M |
| Free Cash Flow | — | — | 513.48M |
| Rev Growth | +18.0% | +18.0% | +4.0% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.99 | -0.08% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.46 | -0.92% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $150.37 | -1.51% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $799.26 | -0.58% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.45 | -2.07% | 40.0 | 32.33B |